SG11201507046UA - Leucine and nicotinic acid reduces lipid levels - Google Patents

Leucine and nicotinic acid reduces lipid levels

Info

Publication number
SG11201507046UA
SG11201507046UA SG11201507046UA SG11201507046UA SG11201507046UA SG 11201507046U A SG11201507046U A SG 11201507046UA SG 11201507046U A SG11201507046U A SG 11201507046UA SG 11201507046U A SG11201507046U A SG 11201507046UA SG 11201507046U A SG11201507046U A SG 11201507046UA
Authority
SG
Singapore
Prior art keywords
leucine
nicotinic acid
lipid levels
acid reduces
reduces lipid
Prior art date
Application number
SG11201507046UA
Inventor
Michael Zemel
Antje Bruckbauer
Original Assignee
Nusirt Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nusirt Sciences Inc filed Critical Nusirt Sciences Inc
Publication of SG11201507046UA publication Critical patent/SG11201507046UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
SG11201507046UA 2013-03-15 2014-03-13 Leucine and nicotinic acid reduces lipid levels SG11201507046UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361800363P 2013-03-15 2013-03-15
PCT/US2014/026816 WO2014152016A1 (en) 2013-03-15 2014-03-13 Leucine and nicotinic acid reduces lipid levels

Publications (1)

Publication Number Publication Date
SG11201507046UA true SG11201507046UA (en) 2015-10-29

Family

ID=51581094

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507046UA SG11201507046UA (en) 2013-03-15 2014-03-13 Leucine and nicotinic acid reduces lipid levels

Country Status (16)

Country Link
US (5) US9585876B2 (en)
EP (1) EP2968333B1 (en)
JP (2) JP6550370B2 (en)
KR (1) KR20150130455A (en)
CN (1) CN105228627B (en)
AU (1) AU2014236687A1 (en)
BR (1) BR112015023310A2 (en)
CA (1) CA2902879C (en)
HK (1) HK1219660A1 (en)
IL (1) IL240762B (en)
MX (1) MX2015011195A (en)
PH (1) PH12015502033A1 (en)
RU (1) RU2015143836A (en)
SG (1) SG11201507046UA (en)
WO (1) WO2014152016A1 (en)
ZA (4) ZA201506481B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014000419A (en) 2011-07-15 2014-09-22 Nusirt Sciences Inc Compositions and methods for modulating metabolic pathways.
CN108295058A (en) 2012-11-13 2018-07-20 纽斯尔特科学公司 Composition for enhancing energetic supersession and method
CN105228627B (en) 2013-03-15 2018-07-13 纽斯尔特科学公司 Leucine and niacin reduce lipid level
SG11201607075TA (en) 2014-02-27 2016-09-29 Nusirt Sciences Inc Compositions and methods for the reduction or prevention of hepatic steatosis
US10323058B2 (en) 2014-07-24 2019-06-18 W. R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
WO2016049236A1 (en) * 2014-09-24 2016-03-31 Nusirt Sciences, Inc. Compositions, methods and kits for treatment of diabetes and/or hyperlipidemia
ES2963057T3 (en) 2015-03-09 2024-03-25 Grace W R & Co Nicotinamide riboside crystalline form
CN107531738B (en) 2015-03-16 2021-02-19 可劳迈戴斯有限公司 Niacinetoside or nicotinamide riboside compositions, reduced derivatives thereof and uses thereof
US11013678B2 (en) 2015-06-29 2021-05-25 The Procter & Gamble Company Multi-component skin care product
US20190262291A1 (en) * 2016-07-19 2019-08-29 Roland W. Winterfield Methods and compositions for alleviating myopathy
JP2019531748A (en) * 2016-10-21 2019-11-07 メタボリック・テクノロジーズ,インコーポレーテッド Compositions and methods using β-hydroxy-β-methylbutyrate (HMB) and probiotics
US10689411B2 (en) 2016-11-11 2020-06-23 The Queen's University Of Belfast Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
CA3044814A1 (en) 2016-11-29 2018-06-07 Charles M. Brenner Use of nad precursors for improving maternal health and/or offspring health
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
SE540582C2 (en) 2016-12-22 2018-10-02 Scandibio Therapeutics Ab Substances for treatment of fatty liver-related conditions
US11286274B2 (en) 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US20210177875A1 (en) * 2017-12-01 2021-06-17 Elysium Health, Inc. Methods and compositions for treating childhood or teen obesity
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
WO2019133815A1 (en) * 2017-12-28 2019-07-04 Kansas State University Research Foundation Nicotinamide riboside treatments of domesticated meat animals
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US10568352B1 (en) 2018-10-25 2020-02-25 Wiser Concepts, LLC Nutritional compositions and methods of treatment therewith
WO2020131578A2 (en) 2018-12-17 2020-06-25 Mitopower Llc Nicotinyl riboside compounds and their uses
US11547693B2 (en) 2019-07-29 2023-01-10 Matthias Rath Ascorbate in the prevention of statin induced vascular calcification
US11938152B2 (en) 2020-08-06 2024-03-26 Kedar N Prasad High-dose antioxidants in cancer treatment
CN116019780A (en) * 2021-10-26 2023-04-28 成都拂尔医药科技有限公司 Double-yellow nano-particles and preparation and application thereof

Family Cites Families (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936527A (en) 1969-12-19 1976-02-03 Damon Corporation Treatment of pets
US3810994A (en) 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
NL7804375A (en) 1977-05-16 1978-11-20 Ralston Purina Co ANIMAL FOOD.
DK150008C (en) 1981-11-20 1987-05-25 Benzon As Alfred PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ORAL POLYDEPOT PREPARATION
US4769027A (en) 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
IE58246B1 (en) 1984-12-21 1993-08-11 Byk Gulden Lomberg Chem Fab Theophylline sustained release formulation
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5087624A (en) 1989-03-21 1992-02-11 Nutrition 21 Chromic picolinate treatment
US5886012A (en) 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
GB8919131D0 (en) 1989-08-23 1989-10-04 Riker Laboratories Inc Inhaler
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
US5250534A (en) 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
JP3219838B2 (en) 1992-05-12 2001-10-15 沖電気工業株式会社 Method for manufacturing semiconductor device
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
LU88369A1 (en) 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Branched chain amino acids
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5395626A (en) 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5616569A (en) 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US6048903A (en) 1994-05-03 2000-04-11 Robert Toppo Treatment for blood cholesterol with trans-resveratrol
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
KR19990077107A (en) 1996-01-09 1999-10-25 코바야시 순이치 Amino acid composition
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ES2164299T5 (en) 1997-01-09 2009-03-01 Societe Des Produits Nestle S.A. CEREAL PRODUCT CONTAINING PROBIOTICS.
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
IT1291113B1 (en) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS
MY125849A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
US6063414A (en) 1997-08-18 2000-05-16 Seal Rock Technologies Incorporated Combination container and dry pet food for increased shelf life, freshness, palatability, and nutritional value
JP3611456B2 (en) 1997-09-30 2005-01-19 日研化学株式会社 Theophylline sustained release tablets
CA2330811A1 (en) 1998-05-04 1999-11-11 Andreas Johannes Kesel Monomeric, oligomeric and polymeric knoevenagel condensation products
DK1083800T3 (en) 1998-06-02 2003-03-17 Biofiber Damino As Method of feeding piglets
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US6403142B1 (en) 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
WO2000035419A2 (en) 1998-12-17 2000-06-22 Alza Corporation Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
BR0008857A (en) 1999-03-08 2001-12-18 Medicure Inc Pyridoxal analogues for vitaminab-6 disorders
FR2790645B1 (en) 1999-03-12 2001-06-08 Arkopharma Laboratoires FOOD SUPPLEMENT AND COSMETIC TREATMENT METHOD BASED ON GRAPE EXTRACT RICH IN POLYPHENOLS
AU7596100A (en) 1999-09-21 2001-04-24 Rutgers, The State University Resveratrol analogs for prevention of disease
US6527711B1 (en) 1999-10-18 2003-03-04 Bodymedia, Inc. Wearable human physiological data sensors and reporting system therefor
US6280779B1 (en) 1999-12-28 2001-08-28 Colgate-Palmolive Company Pet food for maintaining normal bowel health
WO2001058271A1 (en) 2000-01-25 2001-08-16 Juvenon, Inc. Nutritional supplements for aged pets
US7261690B2 (en) 2000-06-16 2007-08-28 Bodymedia, Inc. Apparatus for monitoring health, wellness and fitness
WO2005029242A2 (en) 2000-06-16 2005-03-31 Bodymedia, Inc. System for monitoring and managing body weight and other physiological conditions including iterative and personalized planning, intervention and reporting capability
US6605038B1 (en) 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US7689437B1 (en) 2000-06-16 2010-03-30 Bodymedia, Inc. System for monitoring health, wellness and fitness
US20020165237A1 (en) 2000-08-11 2002-11-07 Fryburg David Albert Treatment of the insulin resistance syndrome
US6384087B1 (en) 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
DK1345500T3 (en) 2000-12-29 2008-11-24 Martin Francis Gannon Animal feed product
WO2002071874A2 (en) 2001-03-09 2002-09-19 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US6338862B1 (en) 2001-03-26 2002-01-15 Sarfaraz K Niazi Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors
US6595929B2 (en) 2001-03-30 2003-07-22 Bodymedia, Inc. System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow
WO2003042362A2 (en) 2001-11-09 2003-05-22 Dana-Farber Cancer Institute, Inc. PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
US20030187055A1 (en) 2002-02-25 2003-10-02 Riker Donald K. Synergistic pharmaceutical combinations for treating obesity
KR101072885B1 (en) 2002-05-17 2011-10-17 듀크 유니버시티 Method for treating obesity
DE60317225T2 (en) 2002-06-26 2008-05-29 Intarcia Therapeutics, Inc., Emeryville MINIMALLY ADVANCED VOLUME-EFFICIENT PISTON FOR OSMOTIC DRUG DISPENSING SYSTEMS
FR2841784B1 (en) 2002-07-08 2007-03-02 COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2EN-1-ONE DERIVATIVES, PREPARATION AND USES
US7020508B2 (en) 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
CA2817028A1 (en) 2002-10-09 2004-04-22 Bodymedia, Inc. Method and apparatus for auto journaling of continuous or discrete body states utilizing physiological and/or contextual parameters
US20050064070A1 (en) 2002-10-11 2005-03-24 Jeffrey Liebrecht Beverage compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
JP2004305201A (en) 2002-11-27 2004-11-04 Hayashibara Biochem Lab Inc Method for controlling formation of acrylamide and use of the same
CN1504424A (en) 2002-12-05 2004-06-16 上海金创投资管理有限公司 Drinking water containing leucine for baby
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
US7288570B2 (en) 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20040120983A1 (en) 2002-12-23 2004-06-24 Philip Connolly Nutritional supplement
MXPA05009811A (en) 2003-03-13 2006-03-08 Red Arrow Products Co Llc Browning composition for application to a film for holding a food product.
US20040186046A1 (en) 2003-03-17 2004-09-23 Pfizer Inc Treatment of type 1 diabetes with PDE5 inhibitors
RU2356247C2 (en) 2003-03-18 2009-05-27 Новартис Аг Combinations and compositions containing fatty acids and amino acids, their application for prevention and delay of progressing or treatment of diabetes and diabetes associated diseases and conditions, method of weight reduction in mammal, kit
US7160565B2 (en) 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US20050042362A1 (en) 2003-04-02 2005-02-24 Clark Harry M. Pet food composition and method
ATE390142T1 (en) 2003-05-14 2008-04-15 Indus Biotech Pvt Ltd SYNERGISTIC COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS
US20070203083A1 (en) 2003-06-13 2007-08-30 Mootha Vamsi K Methods Of Regulating Metabolism And Mitochondrial Function
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
JP2005097273A (en) 2003-08-19 2005-04-14 Toyo Shinyaku:Kk Athletic ability-enhancing composition
KR101084554B1 (en) 2003-09-12 2011-11-17 보디미디어 인코퍼레이티드 Method and apparatus for measuring heart related parameters
CA2544078C (en) 2003-11-03 2013-08-06 Hill's Pet Nutrition, Inc. Coated pet food composition
CN1882592B (en) 2003-11-19 2011-08-10 帝斯曼知识产权资产管理有限公司 Manufacture of vitamin B6
WO2005049006A1 (en) 2003-11-21 2005-06-02 Ajinomoto Co., Inc. Remedy for diabetes
RU2374897C2 (en) 2003-11-26 2009-12-10 Хилл'С Пет Ньютришн, Инк. Method for reduction of smell from pet faeces (versions)
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
JP2007527418A (en) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Composition for treating or preventing obesity and insulin resistance disorders
US20050215882A1 (en) 2004-03-23 2005-09-29 The Regents Of The University Of Michigan Noninvasive method to determine fat content of tissues using MRI
AU2005265031A1 (en) 2004-06-17 2006-01-26 Forest Laboratories, Inc. Modified release formulation of memantine
EP1762234A4 (en) 2004-06-28 2010-05-05 Kao Corp Ampk activator
CN101106997A (en) 2004-08-17 2008-01-16 约翰·霍普金斯大学 PDE5 inhibitor compositions and methods for treating cardiac indications
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1818055A1 (en) 2004-11-29 2007-08-15 Toyo Shinyaku Co., Ltd. Athletic ability enhancing composition
US20060276416A1 (en) * 2005-01-20 2006-12-07 Sirtris Pharmaceuticals, Inc. Methods and compositions for treating flushing and drug induced weight gain
US20060165824A1 (en) 2005-01-26 2006-07-27 The Procter & Gamble Company Compositions, kits, and methods for enhancing gastrointestinal health
SI1845994T1 (en) 2005-02-11 2009-06-30 Argenta Discovery Ltd Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
US20060188611A1 (en) 2005-02-18 2006-08-24 Emine Unlu Edible pet chew
EP1853610A1 (en) 2005-03-03 2007-11-14 Sirtris Pharmaceuticals, Inc. N-phenyl benzamide derivatives as sirtuin modulators
US20070014833A1 (en) 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
ES2376114T3 (en) 2005-05-13 2012-03-09 Nestec S.A. GLUCOSAMINE PRODUCTION FROM VEGETABLE SPECIES.
CA2607600A1 (en) 2005-06-16 2006-12-28 Forest Laboratories, Inc. Modified and immediate release memantine bead formulation
EP1898897A2 (en) * 2005-07-07 2008-03-19 Sirtris Pharmaceuticals, Inc. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
JP2007039367A (en) * 2005-08-02 2007-02-15 Kyoto Univ Composition for promoting cytodifferentiation and its use
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7345178B2 (en) 2005-08-04 2008-03-18 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US20070077310A1 (en) 2005-10-03 2007-04-05 University Of Tennessee Research Foundation Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
CA2631401C (en) 2005-12-02 2013-01-29 Hill's Pet Nutrition, Inc. Methods for altering stool quality and/or stool frequency
US20070185210A1 (en) 2006-01-10 2007-08-09 Yamka Ryan M Compositions and Methods for Promoting Fat Loss
US20110191871A1 (en) 2006-02-28 2011-08-04 Trustees Of Boston University Methods to identify factors associated with muscle growth and uses thereof
DE102006016903A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
US20090182036A1 (en) 2006-05-10 2009-07-16 Krammer-Lukas Stephanie J M Animal food composition comprising genistein and polyunsaturated fatty acids
JP2007306851A (en) 2006-05-18 2007-11-29 仁 ▲吉▼井 Salt composition and method for producing the same
US20070286909A1 (en) 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US20090291958A1 (en) 2006-06-08 2009-11-26 Auspex Pharmaceuticals, Inc. Substituted PDE5 inhibitors
KR101460693B1 (en) 2006-07-12 2014-11-17 유니버시티 오브 테네시 리서치 파운데이션 Substituted acylanilides and methods of use thereof
ITRM20060427A1 (en) 2006-08-04 2008-02-05 Nuraging Biotech S R L COMPOSITIONS ANTIOXIDANTS INCLUDING ROSEMARY AND MIRTUS EXTRACTS
JP5507802B2 (en) 2006-08-10 2014-05-28 花王株式会社 Muscle aging inhibitor
US8703174B2 (en) 2006-09-15 2014-04-22 I Did It Inc Joint preserving nutritional vitamin, mineral and herbal pet supplement
US20080102137A1 (en) * 2006-10-31 2008-05-01 Guffey Manning V R Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
US20080187928A1 (en) 2006-12-29 2008-08-07 The Salk Institute For Biological Studies Methods for enhancing exercise performance
US8431552B2 (en) 2007-01-16 2013-04-30 Chien-Hung Chen Composition for treating metabolic syndrome
US20090006457A1 (en) 2007-02-16 2009-01-01 Stivoric John M Lifeotypes
ATE468025T1 (en) 2007-02-23 2010-06-15 Hills Pet Nutrition Inc COMPOSITIONS AND METHODS FOR WEIGHT CONTROL IN ANIMAL
WO2008115563A1 (en) 2007-03-19 2008-09-25 University Of Florida Research Foundation, Inc. Liquid nutrient composition for improving performance
US20080242727A1 (en) 2007-03-27 2008-10-02 Tim Romero Dietary compositions containing alpha amino n-butyrate and methods of enhancing lean body mass
US20100210692A1 (en) 2007-03-28 2010-08-19 Farmer Stephen R Methods of treatment using sirt modulators and compositions containing sirt1 modulators
US20080268038A1 (en) 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
WO2008143182A1 (en) 2007-05-17 2008-11-27 Kaneka Corporation Composition containing licorice-derived polyphenol
WO2008153945A2 (en) 2007-06-06 2008-12-18 University Of South Florida Nutraceutical co-crystal compositions
US20090054450A1 (en) 2007-06-19 2009-02-26 Ironwood Pharmaceuticals, Inc. Compositions and methods of use for treating or preventing lipid related disorders
TW200918542A (en) 2007-06-20 2009-05-01 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
CL2008001822A1 (en) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compounds derived from thiazolo [5,4-b] pyridine; pharmaceutical composition comprising said compounds; and use of the compound in the treatment of insulin resistance, metabolic syndrome, diabetes, among others.
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US7989007B2 (en) 2007-07-03 2011-08-02 Vincent James Enterprises, Llc Weight loss composition
WO2009003798A1 (en) 2007-07-05 2009-01-08 Unilever N.V. Food composition comprising trans-resveratrol and its use to control blood pressure
WO2009008991A2 (en) 2007-07-06 2009-01-15 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Dna-pkcs modulates energy regulation and brain function
US8529965B2 (en) 2007-07-09 2013-09-10 Hill's Pet Nutrition, Inc. Compositions and methods for altering stool quality in an animal
US8088043B2 (en) 2007-09-07 2012-01-03 Nike, Inc. Wearable device assembly having athletic functionality
US20110082189A1 (en) 2007-10-23 2011-04-07 President And Fellows Of Harvard College Use of compounds activating sirt-3 for mimicking exercise
US20090156648A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
AU2008345571B2 (en) 2007-12-21 2011-10-13 Hill's Pet Nutrition, Inc. Pet food composition
US8716249B2 (en) * 2008-01-31 2014-05-06 Energy Light Llc Compositions and methods for improving cardiovascular health
NZ587165A (en) 2008-02-04 2012-03-30 Mercury Therapeutics Inc Ampk modulators
CN101978374A (en) 2008-03-03 2011-02-16 耐克国际有限公司 Interactive athletic equipment system
AU2009225721B2 (en) 2008-03-17 2014-02-13 The Procter & Gamble Company. User-customizable dosing system
EP2700434A3 (en) 2008-04-02 2014-07-02 Nike International Ltd. Wearable device assembly having athletic functionality
KR20110039249A (en) 2008-07-07 2011-04-15 모치다 세이야쿠 가부시키가이샤 Ameliorating or therapeutic agent for dyslipidemia
US20100021573A1 (en) 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
WO2010019212A2 (en) 2008-08-15 2010-02-18 Nestec S.A. Methods for enhancing energy metabolism
US20100173024A1 (en) 2008-12-01 2010-07-08 LifeSpan Extension, LLC Methods and compositions for altering health, wellbeing, and lifespan
WO2010080976A1 (en) 2009-01-09 2010-07-15 Sdg, Inc. (An Ohio Corporation) Insulin therapies for the treatment of diabetes, diabetes related ailments, and/or diseases or conditions other than diabetes or diabetes related ailments
BRPI1016158A2 (en) 2009-04-26 2016-10-11 Nike International Ltd "system and method for monitoring athletic performance, and system and method for monitoring athletic performance."
US20100303966A1 (en) 2009-05-28 2010-12-02 Gregory Dean Sunvold Pet Food in the Form of a Coated Kibble
US20100303967A1 (en) 2009-05-28 2010-12-02 Gregory Dean Sunvold Pet Food Having Improved Animal Preference
US8377473B2 (en) 2009-07-01 2013-02-19 Magceutics, Inc. Slow release magnesium composition and uses thereof
CN102469812A (en) 2009-07-21 2012-05-23 希尔氏宠物营养品公司 Companion animal nutrition system
US8691303B2 (en) 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US20110064712A1 (en) 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
KR20120081605A (en) 2009-09-18 2012-07-19 폴리페놀레스 나투랄레스, 에스.엘. Method of slowing the aging process by activating sirtuin enzymes with a combination of fucoxanthin and punicic acid
WO2011051974A1 (en) 2009-10-29 2011-05-05 Nutracryst Therapeutics Private Limited Metformin and a-amino acids
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
EP2519115B1 (en) 2009-12-29 2017-02-15 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
WO2011084886A1 (en) 2010-01-06 2011-07-14 Nestec S. A. Dietary regimens useful for mimicking caloric restriction
US20110208153A1 (en) 2010-02-24 2011-08-25 John Alvey Formulations and methods for nutrient delivery
WO2011136159A1 (en) 2010-04-28 2011-11-03 日本薬品株式会社 Composition for the treatment of aesthenopia
US20120058088A1 (en) 2010-06-28 2012-03-08 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Methods Of Use
CN102077936B (en) 2010-09-20 2013-04-24 王强 Special sea dietary food for diabetics
US9167991B2 (en) 2010-09-30 2015-10-27 Fitbit, Inc. Portable monitoring devices and methods of operating same
BR112013017411B1 (en) 2011-01-07 2022-03-22 Anji Pharma (Us) Llc Use of a composition comprising metformin or a salt thereof
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
MX2014000419A (en) * 2011-07-15 2014-09-22 Nusirt Sciences Inc Compositions and methods for modulating metabolic pathways.
MX2014001996A (en) * 2011-08-19 2014-08-29 Musclepharm Corp Compositions and methods for use in promoting lean body mass.
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
KR101409330B1 (en) 2012-05-11 2014-06-18 안국약품 주식회사 Sustained-Release combination preparations for the treatment of diabetes mellitus having enhanced compliance and preparation method thereof
CN108295058A (en) 2012-11-13 2018-07-20 纽斯尔特科学公司 Composition for enhancing energetic supersession and method
EP2945616B1 (en) 2013-01-15 2018-11-28 NuSirt Sciences, Inc. Treating pulmonary conditions
CN105228627B (en) 2013-03-15 2018-07-13 纽斯尔特科学公司 Leucine and niacin reduce lipid level
AU2014238377A1 (en) 2013-03-15 2015-09-10 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
EP3054940B1 (en) 2013-10-07 2020-09-23 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
SG11201607075TA (en) 2014-02-27 2016-09-29 Nusirt Sciences Inc Compositions and methods for the reduction or prevention of hepatic steatosis

Also Published As

Publication number Publication date
IL240762B (en) 2018-11-29
MX2015011195A (en) 2016-03-11
HK1219660A1 (en) 2017-04-13
US20150056274A1 (en) 2015-02-26
IL240762A0 (en) 2015-10-29
US20180214421A1 (en) 2018-08-02
CA2902879A1 (en) 2014-09-25
ZA201506481B (en) 2017-08-30
KR20150130455A (en) 2015-11-23
EP2968333B1 (en) 2022-01-12
EP2968333A1 (en) 2016-01-20
US9707213B2 (en) 2017-07-18
JP6550370B2 (en) 2019-07-24
WO2014152016A1 (en) 2014-09-25
US20160008329A1 (en) 2016-01-14
JP2019065049A (en) 2019-04-25
CN105228627A (en) 2016-01-06
US9895357B2 (en) 2018-02-20
US9408834B2 (en) 2016-08-09
CN105228627B (en) 2018-07-13
ZA201705790B (en) 2018-12-19
EP2968333A4 (en) 2016-11-02
US20170340615A1 (en) 2017-11-30
PH12015502033A1 (en) 2016-01-18
CA2902879C (en) 2023-09-26
US9585876B2 (en) 2017-03-07
US20170000780A1 (en) 2017-01-05
JP2016516040A (en) 2016-06-02
AU2014236687A1 (en) 2015-09-10
ZA201606052B (en) 2018-05-30
BR112015023310A2 (en) 2017-07-18
RU2015143836A (en) 2017-04-27
ZA201805629B (en) 2019-11-27

Similar Documents

Publication Publication Date Title
ZA201805629B (en) Leucine and nicotinic acid reduces lipid levels
HK1217728A1 (en) Cas9-nucleic acid complexes and uses related thereto cas9-
HK1254894A1 (en) Autopilot and methods
GB201306633D0 (en) Biaising circuitry and method thereof
HK1225372A1 (en) Amino acid derivatives
HK1214255A1 (en) 2-acylaminothiazole derivative and salt thereof 2-
EP3085264A4 (en) Fastener
GB201418073D0 (en) Fastener
EP2985503A4 (en) Joining structure and joining method thereof
GB201309178D0 (en) Enzyme and uses thereof
EP3040067A4 (en) Chlorogenic acid powder-injection and preparation method thereof
SG11201500474PA (en) Nutriculture member and nutriculture method
GB201320359D0 (en) Assembly and method
GB201316917D0 (en) Rolling Method
GB201301772D0 (en) Fastener
DK3049043T3 (en) Indirekte tryk- og temperaturmåling i et totalt væskeventilationssystem
GB2515293B (en) Fastener
PL3049517T3 (en) Hetero-transglycosylase and uses thereof
GB201311696D0 (en) Assembly and methods
ZA201407845B (en) Retail aid
EP3050893A4 (en) Glycoamino acid and use thereof
GB2519994B (en) Assemblies and methods
GB201402985D0 (en) Active tagging
GB201317130D0 (en) Fastener
GB201318464D0 (en) Modified enzymes